Cost-Effectiveness of Newborn Screening for Spinal Muscular Atrophy in Australian Hospitals

20252 citationsJournal Articlegold Open Access

Authors

Ian Woodcock

Didu Kariyawasam · Sydney Children’s Hospitals Network

Maina Kava · University of Western Australia

Eppie M. Yiu · University of Melbourne

Damian Clark · Women's and Children's Hospital

Jane Adams · Novartis (Australia)

Matthias Bischof · Novartis (Switzerland)

Abstract

NBS for SMA was dominant compared with no NBS for SMA in Australia from a state and territory payer perspective. Universal implementation of NBS for SMA would support access equity, as well as early diagnosis and treatment in infants with SMA, potentially leading to improved outcomes.

Topics & Keywords

Neurogenetic and Muscular Disorders Research Congenital Anomalies and Fetal Surgery Mechanical Circulatory Support Devices

UN Sustainable Development Goals

Zero hunger

Publication Details

Published in: Neurology and Therapy

Volume 14, Issue 3, pp. 1007-1022

DOI: 10.1007/s40120-025-00744-8

Field-Weighted Citation Impact: 3.48